General Healthcare - European Medical Journal

This site is intended for healthcare professionals

Continue

General Healthcare

Filter
EMJ
27 Aug 2015

Janssen Submits European Extension Marketing Authorisation Application for Paliperidone Palmitate Once-Every-Three-Months Formulation

BEERSE, Belgium, 21st August 2015 – Janssen-Cilag International NV (Janssen) today announced the submission of an Extension Marketing Authorisation…
EMJ
21 Aug 2015

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…
EMJ
23 Jul 2015

Gilead Announces Phase 3 Results from the First Study to Evaluate Switching from TDF-Based Regimens to a TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide (E/C/F/TAF)

VANCOUVER, July 21, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48 week data from an open-label Phase 3 study (Study 109)…
EMJ
2 Jul 2015

SENRI Trial Opens Window to Evaluate NK1 Antagonists for Emesis Prevention in Oxaliplatin Chemotherapy

BARCELONA-LUGANO, 1 July 2015 – The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin…
EMJ
25 Jun 2015

Biosense Webster Launches CARTO® 3 System CONFIDENSE™ Module for Optimized High-Density Mapping During Catheter Ablation Procedures

Diamond Bar, Calif., June 18, 2015 – Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today…
EMJ
17 Jun 2015

New ICS Impulse Transforms Balance Assessment

Taastrup, Denmark | April, 2015 – GN Otometrics, the leading global manufacturer of hearing and balance instrumentation, announced today the…
EMJ
15 Jun 2015

Visualising Calcified Coronary Arteries May Be Wake-Up Call to Change Lifestyle

Dubrovnik, Croatia – 15 June 2015: Looking at images of their own calcified coronary arteries may be a wake-up call for patients with newly diagnosed…
EMJ
26 May 2015

New Data on BIOTRONIK Orsiro Hybrid Drug-Eluting Stent Demonstrates Enhanced Safety and Three-Times Reduced Risk of Stent Thrombosis

BUELACH, Switzerland, May 26, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced that positive new…
We’ve noticed you’re accessing
from North/South America.